Project Grant R43AR081748

Award Date 7/15/22
Completion Date 6/30/24
Dollars Obligated $600K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Greenville, SC 29609, USA
Similar Awards
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, provides $359,995 to Clemson University to develop and validate a novel implantable immunosensor device. The goal is to fabricate an X-ray visualized sensor that can detect and monitor local infection biomarker concentrations around implanted medical devices. This...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering, under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, provides $384,863 to support the development of a novel PET imaging agent for detecting Gram-positive bacterial infections associated with implanted medical devices. The funding will enable researchers at the Washington University Office of Sponsored Research Services to conjugate...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is developing the X-Visual, a sensor to track fracture healing in cannulated screws used for hip fracture fixation. The $299,999 award to Aravis Biotech LLC will cover the design, computational modeling, and initial testing of this innovative device that can non-invasively measure screw bending...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $295,247 will support the development of an innovative medical technology for localized and sustained antibiotic treatment of periprosthetic joint infection. Specifically, the awardee Reselute will design, develop, and validate a proof of concept for an orthopedic spacer implant with a novel porous medium capable of controlled antibiotic elution over 180 days. The implantable...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $440,185 to Georgia Tech Research Corp to engineer antimicrobial hydrogels that can eliminate bacterial infections and promote bone repair in murine and ovine models. The key products and services being delivered under this 5-year, $440,185 award include: 1) developing injectable...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $428,357 to the University of Arizona to develop a new wireless, implantable device that can monitor bone health in small animal models. The 5-year project aims to expand the capabilities of the University's "osseosurface electronics" platform, a battery-free and fully...
This $305,000 SBIR Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The project aims to create a biocompatible and antimicrobial coating to inhibit biofilm formation and protect against bacterial infections, including antibiotic-resistant strains, on orthopedic implants. Key technical objectives include...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award to Reselute, Inc. provides $998,921 to develop a novel implantable orthopedic medical device and procedure to reduce recovery duration and infection risks associated with severe traumatic fractures of the long bones. The project aims to advance a 3D-printed, antibiotic-releasing intramedullary nail to improve upon current standard-of-care implants that are prone to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $317,259 to Scripps Health to develop and test smart, self-powered implant prototypes for total shoulder replacement procedures. The goal is to create prostheses that can continuously monitor joint biomechanics, load conditions, and performance in real-time, with the ability to provide biofeedback to patients and data to healthcare providers. The project will focus on developing smart...
This $250,000 National Science Foundation project grant supports the development of a smart dental implant system to prevent peri-implant diseases through the University of South Florida from October 1, 2022 to December 31, 2025. The project aims to build a strategy for preventing peri-implant disease by enhancing soft tissue immunity against bacterial infection near dental implants. It will develop an ambulatory dental care platform utilizing a human oral motion-powered smart dental implant...

X-RAY VISUALIZED IMPLANTED SENSOR FOR PROSTHETIC JOINT INFECTION (X-VIS-PJI) - ABSTRACT OUR GOAL IS TO FABRICATE AND VALIDATE A NOVEL PH-INDICATING SENSOR WHICH CAN ATTACH TO A HIP PROSTHESIS WITH INTEGRATED SENSORS THAT CAN DETECT AND MONITOR HIP INFECTIONS USING STANDARD OF CARE X-RAY IMAGING. HIP REPLACEMENT SURGERIES ARE PERFORMED ON MILLIONS OF PEOPLE WORLDWIDE EACH YEAR. IN THE UNITED STATES ALONE, THERE WERE 450,000 TOTAL HIP ARTHROPLASTIES PERFORMED ANNUALLY. MOST OF THESE SURGERIES ARE SUCCESSFUL WITH NO COMPLICATIONS. HOWEVER, INFECTIONS ARE A LEADING CAUSE OF FAILURE, WITH AN INCIDENCE OF ABOUT ~0.5-2% OF TOTAL HIP REPLACEMENT SURGERIES. IF DETECTED EARLY, THESE INFECTIONS CAN BE TREATED PROMPTLY WITH ANTIBIOTICS AND SURGICAL DEBRIDEMENT. HOWEVER, MATURE BIOFILMS USUALLY REQUIRE IMPLANT REMOVAL TO TREAT THE INFECTION, FOLLOWED BY REVISION SURGERY WITH ASSOCIATED RISKS OF MORBIDITY, MORTALITY, AND LARGE COST. THEREFORE, IT'S IMPORTANT TO DETECT POST-SURGERY INFECTIONS EARLY AND MONITOR THE EFFECT OF THERAPIES FOR EFFECTIVE TREATMENT. WE HAVE DEVELOPED NOVEL PH-INDICATING SENSORS WHICH CAN ATTACH TO A PROSTHESIS, CAN MEASURE LOCAL INFECTION, AND CAN BE QUANTIFIED USING A STANDARD X-RAY. THIS PHASE I SBIR WILL APPLY THESE PH-INDICATING SENSORS TO THE FEMORAL- NECK OF A HIP PROSTHESIS AND EVALUATE THEIR UTILITY IN A SHEEP MODEL. OUR LONG TERM GOAL IS TO DEVELOP THE FIRST DEVICE THAT ENABLES NONINVASIVE LOCAL PH MEASUREMENTS USING PLAIN RADIOGRAPHY. FURTHER DEVELOPMENT COULD SEE THE SENSOR INTEGRATED INTO THE IMPLANT WITH FURTHER COMMERCIALIZATION PARTNERSHIP. OUR SCIENTIFIC PREMISE IS THAT ACIDOSIS IN VIVO CAN BE MEASURED NONINVASIVELY BY CONVENTIONAL RADIOGRAPHY USING A PH-INDICATING DEVICE FABRICATED USING HYDROGELS THAT RESPOND MECHANICALLY TO THE PRESENCE OF HYDROGEN IONS. PRELIMINARY STUDIES SHOW SUFFICIENT RESPONSE RATE, AND PH SENSITIVITY IN THE EXPECTED PHYSIOLOGICAL PH RANGE. WE WILL REFINE THE PROTOTYPE IN VITRO AND HUMAN CADAVER MODELS, AND VALIDATE THE SENSOR IN VIVO FUNCTION USING AN ANIMAL HIP MODEL IN SHEEP. THE PROPOSED RESEARCH IS SIGNIFICANT BECAUSE IT DEVELOPS A NONINVASIVE METHOD TO DETECT, MONITOR, AND STUDY INFECTION IN SITU WITH THE ULTIMATE POTENTIAL FOR REDUCING MORBIDITY, MORTALITY AND ASSOCIATED COST FROM IMPLANT INFECTIONS.

Posted 7/13/22, 12:00 AM